MGX files 8-K to Furnish Quarterly Results and Investor Deck

Rhea-AI Filing Summary

Metagenomi, Inc. announced its financial results for the quarter ended June 30, 2025 and provided additional business updates. The company furnished a press release and a corporate presentation as Exhibits 99.1 and 99.2 to this Current Report; these exhibits are furnished rather than filed and are not incorporated by reference except as expressly stated in a future filing. The report confirms the company’s common stock trades under the ticker MGX on the Nasdaq Global Select Market and indicates Metagenomi qualifies as an emerging growth company. No financial metrics or operational details are included in the body of this filing.

Insights

Financial Analyst

TL;DR: Routine 8-K furnishing results and investor materials without disclosed metrics; limited immediate valuation impact.

The company furnished a press release and a corporate presentation disclosing results for the quarter ended June 30, 2025, but this filing does not include any financial figures, guidance, or detailed metrics. Because the exhibits are "furnished" and not "filed," liability exposure is limited. For analysts, the material to evaluate is the press release and presentation themselves; the 8-K principally serves as a delivery mechanism. Absent numbers or substantive narrative here, the filing is informational and unlikely to change valuations until the attached exhibits are reviewed.

Corporate Governance Expert

TL;DR: Corporate disclosure procedures followed; exhibits furnished, disclosure scope limited in this form.

From a governance perspective, the company followed standard SEC practice by furnishing an earnings release and investor presentation as exhibits and expressly noting they are furnished, not filed. The report also confirms emerging growth company status, which may affect accounting transition elections. The 8-K includes the CEO signature block, indicating appropriate executive attestation, but provides no additional governance actions or board-level changes. This is a routine disclosure rather than a governance event.

0001785279false00017852792025-08-122025-08-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 12, 2025

Metagenomi, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-41949	81-3909017
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
5959 Horton Street 7th Floor
Emeryville, California				94608
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: (510) 871-4880

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		MGX		Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 2.02 Results of Operations and Financial Condition.

On August 12, 2025, Metagenomi, Inc. (the “Company”) announced its financial results for the quarter ended June 30, 2025 and additional business updates. A copy of the press release in connection with the announcement is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 (including Exhibit 99.1 attached hereto) is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), except as expressly set forth by specific reference in such filing.

Item 7.01 Regulation FD Disclosure.

A copy of the Company’s August 2025 corporate presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in this Item 7.01 (including Exhibit 99.2) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release Issued by Metagenomi, Inc. on August 12, 2025
99.2		Corporate Presentation of Metagenomi, Inc. dated August 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Metagenomi, Inc.
Date:	August 12, 2025	By:	/s/ Brian C. Thomas
			Brian C. Thomas, Ph.D. Chief Executive Officer

FAQ

What did Metagenomi (MGX) disclose in this 8-K?

The company announced it is furnishing a press release (Exhibit 99.1) and a corporate presentation (Exhibit 99.2) regarding financial results for the quarter ended June 30, 2025.

Are the exhibits in the 8-K considered filed for liability purposes?

No. The 8-K states the press release and presentation are furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.

What ticker and exchange does Metagenomi use?

Metagenomi's common stock trades under the ticker MGX on the Nasdaq Global Select Market.

Does the 8-K include financial metrics or earnings figures?

No. The body of the 8-K does not include financial metrics or earnings figures; such details, if any, would be in the attached exhibits.

Does Metagenomi identify as an emerging growth company?

Yes. The filing indicates Metagenomi has checked the box confirming it is an emerging growth company.